Mass screening for colorectal cancer by testing fecal occult blood
β Scribed by Masahide Fujita; Yosuke Nakano; Jun Ohta; Tetsuo Taguchi
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 485 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
T he results of three randomized controlled trials to evaluate the effectiveness of fecal-occult blood (FOB) testing for colorectal carcinoma have been reported. [1][2][3] Two trials of population-based, biennial FOB screening have reported similar results and have led to the claim that the reductio
Following five promotional and educational programs on CBS-TV news in Chicago, 54,101 Hemoccult@ kits were requested by the public and distributed by seven cancer detection facilities. Only 14,074 individuals completed the test. Six hundred and seventeen or 4.38% were positive. Two hundred and fifte
Recently published evidence from two large-scale clinical trials conducted in England and in Denmark suggests that faecal occult blood screening for colorectal cancer significantly reduces mortality. However, before screening can be advocated as part of national health policy, its cost-effectiveness
Mass screening using the faecal occult blood test (FOBT) can reduce mortality from colorectal cancer. Reliable estimation of FOBT sensitivity is crucial in assessing the potential effectiveness of a mass-screening procedure. Available estimates could be inaccurate because they neglect the temporal a